FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $182.7 million versus the consensus estimate of $182.19 million.
GUIDANCE:
Repligen sees FY2023 EPS of $2.35-$2.42, versus the consensus of $2.64. Repligen sees... More

